Skip to main content
Top
Published in: Acta Diabetologica 11/2023

Open Access 20-06-2023 | Celiac Disease | Original Article

Coexisiting type 1 diabetes and celiac disease is associated with lower Hba1c when compared to type 1 diabetes alone: data from the Australasian Diabetes Data Network (ADDN) registry

Authors: Steven James, Lin Perry, Julia Lowe, Kim C. Donaghue, Anna Pham-Short, Maria E. Craig, the ADDN Study Group

Published in: Acta Diabetologica | Issue 11/2023

Login to get access

Abstract

Aim

To compare HbA1c and clinical outcomes in adolescents and young adults with type 1 diabetes (T1D), with or without celiac disease (CD).

Methods

Longitudinal data were extracted from ADDN, a prospective clinical diabetes registry. Inclusion criteria were T1D (with or without CD), ≥ 1 HbA1c measurement, age 16–25 years and diabetes duration ≥ 1 year at last measurement. Multivariable Generalised Estimated Equation models were used for longitudinal analysis of variables associated with HbA1c.

Results

Across all measurements, those with coexisting T1D and CD had lower HbA1c when compared to those with T1D alone (8.5 ± 1.5% (69.4 ± 16.8 mmol/mol) vs. 8.7 ± 1.8% (71.4 ± 19.8 mmol/mol); p < 0.001); lower HbA1c was associated with shorter diabetes duration (B = − 0.06; 95% CI − 0.07 to − 0.05; p < 0.001), male sex (B = − 0.24; − 0.36 to − 0.11; p < 0.001), insulin pump therapy use (B = − 0.46; − 0.58 to − 0.34; p < 0.001), coexistence of T1D and CD (B = − 0.28; − 0.48 to − 0.07; p = 0.01), blood pressure (B = − 0.16; − 0.23 to − 0.09; p < 0.001) and body mass index (B = -− 0.03; − 0.02 to − 0.04; p = 0.01) in the normal range. At last measurement, 11.7% of the total population had a HbA1c < 7.0% (53.0 mmol/mol).

Conclusions

Across all measurements, coexisting T1D and CD is associated with lower HbA1c when compared to T1D alone. However, HbA1c is above target in both groups.
Literature
1.
go back to reference Taczanowska A, Schwandt A, Amed S et al (2021) Celiac disease in children with type 1 diabetes varies around the world: An international, cross-sectional study of 57,375 patients from the SWEET registry. J Diabetes 13(6):448–457CrossRefPubMed Taczanowska A, Schwandt A, Amed S et al (2021) Celiac disease in children with type 1 diabetes varies around the world: An international, cross-sectional study of 57,375 patients from the SWEET registry. J Diabetes 13(6):448–457CrossRefPubMed
2.
go back to reference Bybrant M, Udén E, Frederiksen F et al (2021) Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes. Pediatr Diabetes 22:417–424CrossRef Bybrant M, Udén E, Frederiksen F et al (2021) Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes. Pediatr Diabetes 22:417–424CrossRef
3.
go back to reference Craig M, Prinz N, Boyle CT et al (2017) Prevalence of celiac disease in 52,721 youth with type 1 diabetes: international comparison across three continents. Diabetes Care 40(8):1034–1040CrossRefPubMedPubMedCentral Craig M, Prinz N, Boyle CT et al (2017) Prevalence of celiac disease in 52,721 youth with type 1 diabetes: international comparison across three continents. Diabetes Care 40(8):1034–1040CrossRefPubMedPubMedCentral
4.
go back to reference Gheshlagh R, Rezaei H, Goli M et al (2020) Prevalence of celiac disease in Iranian patients with type 1 diabetes: A systematic review and meta-analysis. Indian J Gastroenterol 39(5):419–425CrossRefPubMed Gheshlagh R, Rezaei H, Goli M et al (2020) Prevalence of celiac disease in Iranian patients with type 1 diabetes: A systematic review and meta-analysis. Indian J Gastroenterol 39(5):419–425CrossRefPubMed
5.
go back to reference Singh P, Arora A, Strand TA et al (2018) Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16(6):823–836CrossRefPubMed Singh P, Arora A, Strand TA et al (2018) Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol 16(6):823–836CrossRefPubMed
6.
go back to reference Pham-Short A, Donaghue KC, Ambler G et al (2019) Abnormal cortical and trabecular bone in youth with type 1 diabetes and celiac disease. Diabetes Care 42(8):1489–1495CrossRefPubMed Pham-Short A, Donaghue KC, Ambler G et al (2019) Abnormal cortical and trabecular bone in youth with type 1 diabetes and celiac disease. Diabetes Care 42(8):1489–1495CrossRefPubMed
7.
go back to reference Leeds J, Hopper AD, Hadjivassiliou M et al (2011) High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 34(10):2158–2163CrossRefPubMedPubMedCentral Leeds J, Hopper AD, Hadjivassiliou M et al (2011) High prevalence of microvascular complications in adults with type 1 diabetes and newly diagnosed celiac disease. Diabetes Care 34(10):2158–2163CrossRefPubMedPubMedCentral
8.
go back to reference Mollazadegan K, Kugelberg M, Montgomery SM et al (2013) A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Diabetes Care 36:316–321CrossRefPubMedPubMedCentral Mollazadegan K, Kugelberg M, Montgomery SM et al (2013) A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Diabetes Care 36:316–321CrossRefPubMedPubMedCentral
9.
go back to reference Rohrer T, Wolf J, Liptay S et al (2015) Microvascular complications in childhood-onset type 1 diabetes and celiac disease: a multicenter longitudinal analysis of 56,514 patients from the German-Austrian DPV database. Diabetes Care 38(5):801–807CrossRefPubMed Rohrer T, Wolf J, Liptay S et al (2015) Microvascular complications in childhood-onset type 1 diabetes and celiac disease: a multicenter longitudinal analysis of 56,514 patients from the German-Austrian DPV database. Diabetes Care 38(5):801–807CrossRefPubMed
10.
go back to reference Bakker S, Tushuizen ME, von Blomberg ME et al (2013) Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications. Acta Diabetol 50(3):319–324CrossRefPubMed Bakker S, Tushuizen ME, von Blomberg ME et al (2013) Type 1 diabetes and celiac disease in adults: glycemic control and diabetic complications. Acta Diabetol 50(3):319–324CrossRefPubMed
11.
go back to reference Pham-Short A, Donaghue K, Ambler G et al (2014) Early elevation of albumin excretion rate is associated with poor gluten-free diet adherence in young people with coeliac disease and diabetes. Diabet Med 31(2):208–212CrossRefPubMed Pham-Short A, Donaghue K, Ambler G et al (2014) Early elevation of albumin excretion rate is associated with poor gluten-free diet adherence in young people with coeliac disease and diabetes. Diabet Med 31(2):208–212CrossRefPubMed
12.
go back to reference Malalasekera V, Cameron F, Grixti E et al (2009) Potential reno-protective effects of a gluten-free diet in type 1 diabetes. Diabetologia 52(5):798–800CrossRefPubMed Malalasekera V, Cameron F, Grixti E et al (2009) Potential reno-protective effects of a gluten-free diet in type 1 diabetes. Diabetologia 52(5):798–800CrossRefPubMed
13.
go back to reference Mollazadegan K, Fored M, Lundberg S et al (2014) Risk of renal disease in patients with both type 1 diabetes and coeliac disease. Diabetologia 57(7):1339–1345CrossRefPubMed Mollazadegan K, Fored M, Lundberg S et al (2014) Risk of renal disease in patients with both type 1 diabetes and coeliac disease. Diabetologia 57(7):1339–1345CrossRefPubMed
14.
go back to reference Creanza A, Lupoli R, Lembo E et al (2018) Glycemic control and microvascular complications in adults with type 1 diabetes and long-lasting treated celiac disease: A case-control study. Diabetes Res Clin Pract 143:282–287CrossRefPubMed Creanza A, Lupoli R, Lembo E et al (2018) Glycemic control and microvascular complications in adults with type 1 diabetes and long-lasting treated celiac disease: A case-control study. Diabetes Res Clin Pract 143:282–287CrossRefPubMed
15.
go back to reference Mozzillo E, Franceschi R, Di Candia F et al (2022) The impact of gluten-free diet on growth, metabolic control and quality of life in youth with type 1 diabetes and celiac disease: a systematic review. Diabetes Res Clin Pract 191:110032CrossRefPubMed Mozzillo E, Franceschi R, Di Candia F et al (2022) The impact of gluten-free diet on growth, metabolic control and quality of life in youth with type 1 diabetes and celiac disease: a systematic review. Diabetes Res Clin Pract 191:110032CrossRefPubMed
16.
go back to reference Dovey-Pearce G, Hurrell R, May C (2005) Young adults (16–25 years) suggestions for providing developmentally appropriate diabetes services: a qualitative study. Health Soc Care Comm 13:409–419CrossRef Dovey-Pearce G, Hurrell R, May C (2005) Young adults (16–25 years) suggestions for providing developmentally appropriate diabetes services: a qualitative study. Health Soc Care Comm 13:409–419CrossRef
17.
go back to reference James S, Perry L, Lowe J et al (2022) Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: data from the Australasian Diabetes Data Network registry. Pediatr Diabetes 23(6):736–741CrossRefPubMed James S, Perry L, Lowe J et al (2022) Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: data from the Australasian Diabetes Data Network registry. Pediatr Diabetes 23(6):736–741CrossRefPubMed
18.
go back to reference James S, Perry L, Gallagher R et al (2020) A discussion of healthcare support for adolescents and young adults with long-term conditions: current policy and practice and future opportunities. Int J Nurs Pract 26(5):e12882 James S, Perry L, Gallagher R et al (2020) A discussion of healthcare support for adolescents and young adults with long-term conditions: current policy and practice and future opportunities. Int J Nurs Pract 26(5):e12882
19.
go back to reference Phelan H, Clapin H, Bruns L et al (2017) The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes. Med J Aust 206(3):121–125CrossRefPubMed Phelan H, Clapin H, Bruns L et al (2017) The Australasian Diabetes Data Network: first national audit of children and adolescents with type 1 diabetes. Med J Aust 206(3):121–125CrossRefPubMed
22.
go back to reference Di Meglio L, Acerini CL, Codner E et al (2018) 2018 ISPAD Clinical Practice Consensus Guidelines: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 19:105–114CrossRef Di Meglio L, Acerini CL, Codner E et al (2018) 2018 ISPAD Clinical Practice Consensus Guidelines: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes 19:105–114CrossRef
23.
go back to reference Kordonouri O, Klingensmith G, Knip M et al (2014) Other complications and diabetes associated conditions in children and adolescents. Pediatr Diabetes 15:270–278CrossRefPubMed Kordonouri O, Klingensmith G, Knip M et al (2014) Other complications and diabetes associated conditions in children and adolescents. Pediatr Diabetes 15:270–278CrossRefPubMed
24.
go back to reference Fröhlich-Reiterer E, Elbarbary NS, Simmons K et al (2022) ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 23(8):1451–1467CrossRefPubMed Fröhlich-Reiterer E, Elbarbary NS, Simmons K et al (2022) ISPAD Clinical Practice Consensus Guidelines 2022: Other complications and associated conditions in children and adolescents with type 1 diabetes. Pediatr Diabetes 23(8):1451–1467CrossRefPubMed
25.
go back to reference Pham-Short A, Donaghue KC, Ambler G et al (2015) Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review. Pediatrics 136:e170CrossRefPubMed Pham-Short A, Donaghue KC, Ambler G et al (2015) Screening for Celiac Disease in Type 1 Diabetes: A Systematic Review. Pediatrics 136:e170CrossRefPubMed
26.
go back to reference Dixit R, Lebwohl B, Ludvigsson JF et al (2014) Celiac disease is diagnosed less frequently in young adult males. Dig Dis Sci 59(7):1509–1512CrossRefPubMed Dixit R, Lebwohl B, Ludvigsson JF et al (2014) Celiac disease is diagnosed less frequently in young adult males. Dig Dis Sci 59(7):1509–1512CrossRefPubMed
27.
go back to reference Australian Type 1 Diabetes Guidelines Expert Advisory Group, National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Australian Government: Canberra. 2011. Australian Type 1 Diabetes Guidelines Expert Advisory Group, National evidence-based clinical care guidelines for type 1 diabetes in children, adolescents and adults. Australian Government: Canberra. 2011.
29.
go back to reference King J, Jeong J, Underwood FE et al (2020) Incidence of celiac disease is increasing over time: a systematic review and meta-analysis. Am J Gastroenterol 115(4):507–552CrossRefPubMed King J, Jeong J, Underwood FE et al (2020) Incidence of celiac disease is increasing over time: a systematic review and meta-analysis. Am J Gastroenterol 115(4):507–552CrossRefPubMed
Metadata
Title
Coexisiting type 1 diabetes and celiac disease is associated with lower Hba1c when compared to type 1 diabetes alone: data from the Australasian Diabetes Data Network (ADDN) registry
Authors
Steven James
Lin Perry
Julia Lowe
Kim C. Donaghue
Anna Pham-Short
Maria E. Craig
the ADDN Study Group
Publication date
20-06-2023
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 11/2023
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-023-02113-z

Other articles of this Issue 11/2023

Acta Diabetologica 11/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine